There has been intense discussion lately about the risks associated with breast implants. France has gone so far as to ban the use of textured breast implants – an act that occurred earlier this month.
Solana Beach, CA-based Puregraft has developed an option other than an implant – a technology that would use a patient’s own fat, for breast augmentation, or restructuring.
“Fat transfer, believe it or not, is the most popular procedure that you’ve never heard of,” Brad Conlan, Puregraft CEO, told MD+DI. “The first fat transfer on the books happened in the late 1800s. The question has always been if it’s so great why isn’t it [used more].”
One of the biggest markets for Puregraft is France, which is the first country to ban the implants. The ban covers macro-textured implants and implants with a polyurethane coating. The National Agency for Safety of Medicines and Health Products (ANSM) in France notified manufacturers of the ban last week.
The ANSM said it has not found a causal link between ALCL and the textured breast implants, but it is imposing the ban nonetheless as a « precautionary measure. » Since 2011, 59 cases have been reported in France, and most women affected by the disease had textured breast implants…